Based on the proven technology of the original Capillarys instrument, the new system features cap piercing for analysis of whole blood directly from primary sample tubes.
For haemoglobinopathy testing, the new cap-piercing capability streamlines workflow and maximises biohazard safety. Once primary sample tubes are loaded onto the system, the sample rack is gently inverted to ensure whole blood samples remain homogeneous and produce accurate results. Positive sample identification ensures full traceability from primary tube to final result.
Chris Plows, general manager of Sebia UK, commented: “We are very pleased with the improved capabilities Capillarys 2 Flex Piercing offers clinical laboratories. Our R&D experts have developed a system that allows haemoglobinopathy testing to be carried out on the same platform as protein analysis, direct from primary sample tubes.”
In addition to haemoglobin variant analysis, the comprehensive menu includes tests for serum and urine proteins, immunotyping, carbohydrate-deficient transferrin, as well as high-resolution immunofixation. With eight simultaneous migrations and a throughput of 34 haemoglobin samples and 80 protein samples an hour, Capillarys helps Biomedical Scientists provide fast, precise results.